Aging Well: Using Precision to Drive Down Costs and Increase Health Quality-Advances in Geriatric Medicine and Research-CSCIED科技核心评价数据库-手机版

Aging Well: Using Precision to Drive Down Costs and Increase Health Quality

Aging Well: Using Precision to Drive Down Costs and Increase Health Quality

ES评分 0 浏览量：885 下载量：0

DOI	10.20900/agmr20190003
刊名	Advances in Geriatric Medicine and Research AGMR
年，卷(期)	2019, 1(1)
作者	Rhoda Au*,Marina Ritchie,Spencer Hardy,Ting Fang Alvin Ang,Honghuang Lin,
作者单位	1 Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA; 2 Framingham Heart Study, National Heart, Lung, and Blood Institute, Boston, MA 01702, USA; 3 Department of Epidemiology, Boston University School of Public Health, Boston, MA 02118, USA; 4 Department of Anatomy & Neurobiology, Boston University School of Medicine, Boston, MA 02118, USA; 5 Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
Abstract	Efforts to provide patients with individualized treatments have led to tremendous breakthroughs in healthcare. However, a precision medicine approach alone will not offset the rapid increase in prevalence and burden of chronic non-communicable illnesses that is continuing to pervade the world’s aging population. With rapid advances in technology, it is now possible to collect digital metrics to assess, monitor and detect chronic disease indicators, much earlier in the disease course, potentially redefining what was previously considered asymptomatic to pre-symptomatic. Data science and artificial intelligence can drive the discovery of digital biomarkers before the emergence of overt clinical symptoms, thereby transforming the current healthcare approach from one centered on precision medicine to a more comprehensive focus on precision health, and by doing so enable the possibility of preventing disease altogether. Presented herein are the challenges to the current healthcare model and the proposition of first steps for reversing the prevailing intractable trend of rising healthcare costs and poorer health quality.
KeyWord	KEYWORDS: digital biomarkers; precision health; aging
基金项目
页码	-

参考文献
相关文献

1.United Nations, Department of Economic and Social Affairs, Population Division. World Population Ageing. New York (US): United Nations; 2017. ST/ESA/SER.A/408.

2.United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2017 Revision, Key Findings and Advance Tables. New York (US): United Nations; 2017. Working Paper No.: ESA/P/WP/248.

3.World Health Organization. Global health and aging. Geneva (Switzerland): World Health Organization; 2011 Oct. NIH Publication No.: 11-7737. Available from: https://www.who.int/ageing/publications/global_health.pdf. Accessed 2019 May 16.

4.Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0

5.Suzman R, Beard JR, Boerma T, Chatterji S. Health in an ageing world—what do we know? Lancet. 2015;385(9967):484-6. doi: 10.1016/S0140-6736(14) 61597-X

6.Fuellen G, Jansen L, Cohen AA, Luyten W, Gogol M, Simm A, et al. Health and Aging: Unifying Concepts, Scores, Biomarkers and Pathways. Aging Dis. 2018; doi:10.14336/AD.2018.1030

7.Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The Global Economic Burden of Non-communicable Diseases. Geneva: World Economic Forum; 2011.

8.Papanicolas I, Woskie L, Jha A. Health care spending in the United States and other high-income countries. JAMA. 2018;319(10):1024-39. doi:10.1001/jama.2018.1150.

9.Centers for Disease Control and Prevention. Chronic disease prevention and health promotion. Available from: http://www.cdc.gov/chronicdisease/overview/ index.htm#ref2. Accessed 2019 Apr 4.

10.World Health Organization. The world health report 2000 health systems: Improving performance. Geneva (Switzerland): World Health Organization; 2000. Available from: https://www.who.int/whr/2000/en/. Accessed 2019 Apr 2.

11.Siegel R, Miller K, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi:10.3322/caac.21442

12.Benjamin E, Muntner P, Alonso A, Bittencourt M, Callaway C, Carson A, et al. Heart disease and stroke statistics—2019 update: A report from the American Heart Association. Circulation. 2019;139(10):e56-8. doi: 10.1161/CIR.0000000000000659

13.Domestic Public Health Achievements Team, Centers for Disease Control and Prevention. Ten great public health achievements—United States, 2001-2010. Morb Mortal Wkly Rep. 2011;60(19):619-23.

14.World Health Organization. HIV: from a devastating epidemic to a manageable chronic disease. Geneva (Switzerland): World Health Organization; 2017.

15.Hodson, R. Precision medicine. Nature. 2016;537(7619):S49. doi: 10.1038/537S49a

16.National Cancer Institute. Precision medicine in cancer treatment. Available from: https://www.cancer.gov/about-cancer/treatment/types/precision-medicine. Accessed 2019 May 16.

17.National Cancer Institute. Targeted cancer therapies fact sheet. Available from: https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet. Accessed 2019 May 16.

18.De Bono JS, Ashworth A. Translating cancer research into targeted therapeutics. Nature. 2010;467(7315):543-9. doi: 10.1038/nature09339

19.Friedman AA, Letai A, Fisher DE, Flaherty KT. Precision medicine for cancer with next-generation functional diagnostics. Nat Rev Cancer. 2015;15(12):747-56. doi: 10.1038/nrc4015

20.World Health Organization. Preventing chronic diseases: a vital investment. Geneva (Switzerland): World Health Organization; 2005.

21.O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang, H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016;388(10046):761-75. doi: 10.1016/S0140-6736(16)30506-2

22.Islami F, Goding Sauer A, Miller K, Siegel R, Fedewa S, Jacobs E, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31-54. doi: 10.3322/caac.21440

23.Adams ML, Grandpre J, Katz DL, Shenson D. The impact of key modifiable risk factors on leading chronic conditions. Prev Med. 2019;120:113-8. doi: 10.1016/j.ypmed.2019.01.006

24.Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: The effects of a small BMI reduction at population level. BMC Public Health. 2014;14:143. doi: 10.1186/1471-2458-14-143

25.Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162(16):1867-72.

26.Schmidt H. Chronic disease prevention and health promotion. In: Barrett DH, Ortmann LH, Dawson A, Saenz C, Reis A, Bolan G, editors. Public Health Ethics: Cases Spanning the Globe. Cham (Switzerland): Springer; 2016. Chapter 5.

27.Allen P, Sequeira S, Best L, Jones E, Baker E, Brownson R. Perceived benefits and challenges of coordinated approaches to chronic disease prevention in state health departments. Prev Chronic Dis. 2014;11:E76. doi: 10.5888/pcd11.130350

28.Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: A randomised controlled trial. Lancet. 2015;385(9978):1642-52. doi: 10.1016/S0140-6736(15)60123-4

29.World Health Organization. WHO report on the global tobacco epidemic, 2008 the MPOWER package. Geneva (Switzerland): World Health Organization; 2008. Available from: https://www.who.int/tobacco/mpower/ mpower_report_full_2008.pdf. Accessed 2019 May 16.

30.Golechha M. Health promotion methods for smoking prevention and cessation: A comprehensive review of effectiveness and the way forward. Int J Prev Med. 2016;7:7. doi: 10.4103/2008-7802.173797

31.Kansagra SM, Kennelly MO, Nonas CA, Curtis CJ, Van Wye G, Goodman A, et al. Reducing sugary drink consumption: New York City's approach. Am J Public Health. 2015;105(4):e61-4. doi: 10.2105/AJPH.2014.302497

32.Britton A, Shipley M, Singh-Manoux A, Marmot MG. Successful aging: The contribution of early-life and midlife risk factors. J Am Geriatr Soc. 2008;56(6):1098-105. doi: 10.1111/j.1532-5415.2008.01740.x

33.Yaffe K, Vittinghoff E, Pletcher MJ, Hoang TD, Launer LJ, Whitmer R, et al. Early adult to midlife cardiovascular risk factors and cognitive function. Circulation. 2014;129(15):1560-7. doi: 10.1161/CIRCULATIONAHA.113.004798

34.Kivipelto M, Mangialasche F, Ngandu T. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol. 2018;14(11):653-66. doi: 10.1038/s41582-018-0070-3

35.Anderko L, Roffenbender J, Goetzel R, Millard F, Wildenhaus K, DeSantis C, et al. Promoting prevention through the Affordable Care Act: Workplace wellness. Prev Chronic Dis. 2012;9:E175. doi: 10.5888/pcd9.120092

36.U.S. Food and Drug Administration. Digital health. Available from: https://www.fda.gov/medicaldevices/digitalhealth/. Accessed 2019 Apr 4.

37.National Institutes of Health. All of Us Research Program. Available from: https://allofus.nih.gov/. Accessed 2019 May 16.

38.National Institute on Aging. New opportunities announced for next-gen Alzheimer's Disease Research Centers grants. Available from: https://www.nia.nih.gov/research/blog/2018/02/new-opportunities-announced-next-gen-alzheimers-disease-research-centers. Accessed 2019 Apr 04.

39.Diagnostics Accelerator: Digital Biomarkers. Available from: https://www.alzdiscovery.org/research-and-grants/funding-opportunities/digital-biomarkers. Accessed 2019 May 16.

40.Karpman C, Lebrasseur N, Kotajarvi B, Benzo R. Gait speed in patients with chronic obstructive pulmonary disease (COPD): Protocol testing and association between 6-minute walk test (6mwt) and daily physical activity. Int J Chron Obstruct Pulmon Dis. 2014;9:1315-20. doi: 10.2147/COPD.S54481

41.Pepera GK, Sandercock GR, Sloan R, Cleland JJ, Ingle L, Clark AL. Influence of step length on 6-minute walk test performance in patients with chronic heart failure. Physiotherapy. 2012;98(4):325-9. doi: 10.1016/j.physio.2011.08.005

42.Witherspoon JW, Vasavada RP, Waite MR, Shelton M, Chrismer IC, Wakim PG, et al. 6-minute walk test as a measure of disease progression and fatigability in a cohort of individuals with RYR1-related myopathies. Orphanet J Rare Dis. 2018;13(1):105. doi: 10.1186/s13023-018-0848-9

43.Kobayashi E, Himuro N, Takahashi M. Clinical utility of the 6-min walk test for patients with moderate Parkinson's disease. Int J Rehabil Res. 2017;40(1):66-70. doi: 10.1097/MRR.0000000000000205

44.Brach JS, Talkowski JB, Strotmeyer ES, Newman AB. Diabetes mellitus and gait dysfunction: Possible explanatory factors. Phys Ther. 2008;88(11):1365-74. doi: 10.2522/ptj.20080016

45.Nishiwaki Y, Breeze E, Smeeth L, Bulpitt C, Peters R, Fletcher A. Validity of the clock-drawing test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol. 2004;160(8):797-807.

46.Souillard-Mandar W, Davis R, Rudin C, Au R, Libon DJ, Swenson R. Learning classification models of cognitive conditions from subtle behaviors in the digital clock drawing test. Mach Learn. 2016;102(3):393-441. doi:10.1007/s10994-015-5529-5

47.Alhanai T, Au R, Glass J. Spoken Language Biomarkers for Detecting Cognitive Impairment. In IEEE Proceedings of Automatic Speech Recognition and Understanding Workshop (ASRU); 2017 Dec 16-20; Okinawa, Japan. Piscataway (US): IEEE; 2017. doi:10.1109/ASRU.2017.8268965

48.Downey CL, Chapman S, Randell R, Brown JM, Jayne DG. The impact of continuous versus intermittent vital signs monitoring in hospitals: A systematic review and narrative synthesis. Int J Nur Stud. 2018;84:19-27. doi: 10.1016/j.ijnurstu.2018.04.013

49.Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst.2014;2:3. doi: 10.1186/2047-2501-2-3

50.Lee CH, Yoon HJ. Medical big data: promise and challenges. Kidney Res Clin Prac. 2017;36(1):3–11. doi: 10.23876/j.krcp.2017.36.1.3

51.Taylor K, Silver L. Smartphone Ownership Is Growing Rapidly Around the World, but Not Always Equally. Available From: https://www.pewglobal.org/2019/02/05/smartphone-ownership-is-growing-rapidly-around-the-world-but-not-always-equally/. Accessed 2019 May 16.

52.Bot BM, Suver C, Neto EC, Kellen M, Klein A, Bare C, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data. 2016;3:160011. doi: 10.1038/sdata.2016.11

53.Dorsey ER, Yvonne Chan YF, McConnell MV, Shaw SY, Trister AD, Friend SH. The use of smartphones for health research. Acad Med. 2017;92(2):157-60. doi: 10.1097/ACM.0000000000001205

54.Kakkar AK, Sarma P, Medhi B. mHealth technologies in clinical trials: Opportunities and challenges. Indian J Pharmacol. 2018;50(3):105-7. doi: 10.4103/ijp.IJP_391_18

55.Mayo CS, Matuszak MM, Schipper MJ, Jolly S, Hayman JA, Ten Haken RK. Big Data in Designing Clinical Trials: Opportunities and Challenges. Front Oncol. 2017;7:187. doi: 10.3389/fonc.2017.00187

56.Sage Bionetworks. AMP-AD Knowledge Portal. Available from: https://www.synapse.org/#!Synapse:syn2580853/wiki/409840. Accessed 2019 May 16.

57.University of Michigan Institute for Social Research. HRS Data Products. Available from: https://hrs.isr.umich.edu/data-products. Accessed 2019 May 16.

58.El Emam K, Jonker E, Arbuckle L, Malin B. A systematic review of re-identification attacks on health data. PLoS One. 2011;6(12). doi: 10.1371/journal.pone.0028071

59.Kayaalp M. Modes of De-identification. AMIA Annu Symp Proc. 2017;2017:1044-50.

60.Fuellen G, Schofield P, Flatt T, Schulz RJ, Boege F, Kraft K, et al. Living Long and Well: Prospects for a Personalized Approach to the Medicine of Ageing. Gerontology. 2016;62:409-16. doi: 10.1159/000442746

引用本文

Rhoda Au*,Marina Ritchie,Spencer Hardy,Ting Fang Alvin Ang,Honghuang Lin. Aging Well: Using Precision to Drive Down Costs and Increase Health Quality, Advances in Geriatric Medicine and Research. 2019; 1; (1). https://doi.org/10.20900/agmr20190003.

文献评论

相关学者

相关机构